ALT5 Sigma Corporation Common StockALTS
About: ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.
Employees: 10
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
800% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 1
500% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 2
47% more funds holding
Funds holding: 17 [Q4 2024] → 25 (+8) [Q1 2025]
24% more capital invested
Capital invested by funds: $4.23M [Q4 2024] → $5.25M (+$1.02M) [Q1 2025]
3.14% more ownership
Funds ownership: 6.46% [Q4 2024] → 9.61% (+3.14%) [Q1 2025]
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $116K
Research analyst outlook
We haven’t received any recent analyst ratings for ALTS.
Financial journalist opinion
Based on 4 articles about ALTS published over the past 30 days









